This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
oncology-screening: Archive
Is Fidelity Blue Chip Growth (FBGRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FBGRX
FBGRXPositive Net Change
equity immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Is T. Rowe Price Health Sciences (PRHSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PRHSX
PRHSXPositive Net Change
equity immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Is Kinetics Global Fund No Load (WWWEX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for WWWEX
WWWEXPositive Net Change
equity immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Is Vanguard Wellesley Income Investor (VWINX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VWINX
VWINXPositive Net Change
equity immuno-therapy medical-devices messenger-rna mutual-funds oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Should Invesco S&P 500 Enhanced Value ETF (SPVU) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPVU
SPVUPositive Net Change TNegative Net Change WMTNegative Net Change VTVPositive Net Change IWDPositive Net Change
dividend etf expenses gambling holdings immuno-therapy index market-capitalization medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Should You Invest in the iShares U.S. BrokerDealers & Securities Exchanges ETF (IAI)?
by Zacks Equity Research
Sector ETF report for IAI
IAIPositive Net Change GSPositive Net Change MSPositive Net Change ICEPositive Net Change KCEPositive Net Change
apparel dividend etf expenses hmo holdings hospitals immuno-therapy index medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media us-equities vaccines
Is iShares MSCI Intl Multifactor ETF (INTF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for INTF
INTFPositive Net Change INVEPositive Net Change VEAPositive Net Change VXUSPositive Net Change
dividend etf expenses holdings immuno-therapy index medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Why SAIC (SAIC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SAICPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing growth-investors growth-stocks high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why Centene (CNC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CNCPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing growth-investors growth-stocks high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Down 10.2% in 4 Weeks, Here's Why Fidelity National (FIS) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Fidelity National (FIS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
FISPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing rsi saas self-driving-cars smart-health social-media stock-price-movement vaccines
Down 12.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Global Payments (GPN)
by Zacks Equity Research
Global Payments (GPN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
GPNPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing rsi saas self-driving-cars smart-health social-media stock-price-movement vaccines
New to Investing? This 1 Basic Materials Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
CEPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-estimates fin-tech furniture-retailers gene-editing gene-therapy growth-investing home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-consensus-estimate zacks-rank
Why Capital One (COF) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
COFPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked undervalued-stocks vaccines value-stocks
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NVSPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Toyota Motor Corporation (TM) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Toyota Motor Corporation (TM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
TMPositive Net Change
automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-surprise fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-change ride-hailing saas self-driving-cars smart-health social-media style-scores vaccines valuation
Volt Information (VOLT) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Volt Information (VOLT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
VOLTPositive Net Change
automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-surprise fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-change ride-hailing saas self-driving-cars smart-health social-media style-scores vaccines valuation
Dick's (DKS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Dick's (DKS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DKSPositive Net Change TSCOPositive Net Change AZONegative Net Change WOOFPositive Net Change
automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-surprise fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-change ride-hailing saas self-driving-cars smart-health social-media style-scores vaccines valuation
ON Semiconductor Corp. (ON) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
ON Semiconductor Corp. (ON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ONPositive Net Change
automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-surprise fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-change ride-hailing saas self-driving-cars smart-health social-media style-scores vaccines valuation
Perficient (PRFT) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Perficient (PRFT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PRFTPositive Net Change
automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-surprise fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-change ride-hailing saas self-driving-cars smart-health social-media style-scores vaccines valuation
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CCPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why Agco (AGCO) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AGCOPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ACGLNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
The Zacks Rank Explained: How to Find Strong Buy Construction Stocks
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
KBHPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank
This Top Retail and Wholesale Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
LADPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank
This Top Retail and Wholesale Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
ORLYNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank